BX 471
Alternative Names: BAY 865047; CCR1 - Bayer Healthcare; CCR1 antagonist - Bayer Healthcare; SH T 04268H; ZK-811752Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Developer Bayer HealthCare Pharmaceuticals Inc.
- Class Phenylurea compounds; Piperidines; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action CCR1 receptor antagonists; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Endometriosis; Multiple myeloma; Multiple sclerosis; Psoriasis
Most Recent Events
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer Healthcare Pharmaceuticals
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
- 29 Dec 2006 Schering AG is now called Bayer Schering Pharma